参考文献/References:
[1] Cao X, Tay A, Guy GR, et al.Activation and association of Stat3 with Src in v-Src-transformed cell lines[J].Mol Cell Biol, 1996, 16(4):1595-1603.DOI:10.1128/MCB.16.4.1595.
[2] Yuan X, Du J, Hua S, et al.Suppression of autophagy augments the radiosensitizing effects of STAT3 inhibition on human glioma cells[J].Exp Cell Res, 2015, 330(2):267-276.DOI:10.1016/j.yexcr.2014.09.006.
[3] Lütticken C, Wegenka UM, Yuan J, et al.Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130[J].Science, 1994, 263(5143):89-92.DOI:10.1126/science.8272872.
[4] Ren Z, Mao X, Mertens C, et al.Crystal structure of unphosphorylated STAT3 core fragment[J].Biochem Biophys Res Commun, 2008, 374(1):1-5.DOI:10.1016/j.bbrc.2008.04.049.
[5] Maritano D, Sugrue ML, Tininini S, et al.The STAT3 isoforms alpha and beta have unique and specific functions[J].Nat Immunol, 2004, 5(4):401-409.DOI:10.1038/ni1052.
[6] Wake MS, Watson CJ.STAT3 the oncogene-still eluding therapy?[J].FEBS J, 2015, 282(14):2600-2611.DOI:10.1111/febs.13285.
[7] Bharti AC, Donato N, Aggarwal BB.Curcurnin(diferuloylmethane)inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells[J].J Immunol, 2003, 171(7):3863-3871.DOI:10.4049/jimmunol.171.7.3863.
[8] Inghirami G, Chiarle R, Simmons WJ, et al.New and old functions of STAT3:a pivotal target for individualized treatment of cancer[J].Cell Cycle, 2005, 4(9):1131-1133.
[9] Yu H, Jove R.The stats of cancer-New molecular targets come of age[J].Nat Rev Cancer, 2004, 4(2):97-105.DOI:10.1038/nrc1275.DOI:10.1038/nrc1275.
[10] Subramaniam A, Shanmugam MK, Perumal E, et al.Potential role of signal transducer and activator of transcription(STAT) 3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma[J].Biochim Biophys Acta, 2013, 1835(1):46-60.DOI:10.1016/j.bbcan.2012.10.002.
[11] Siveen KS, Sikka S, Surana R, et al.Targeting the STAT3 signaling pathway in cancer:role of synthetic and natural inhibitors[J].Biochim Biophys Acta, 2014, 1845(2):136-154.DOI:10.1016/j.bbcan.2013.12.005.
[12] Ferguson SD, Srinivasan VM, Heimberger AB.The role of STAT3 in tumor-mediated immune suppression[J].J Neurooncol, 2015, 123(3):385-394.DOI:10.1007/s11060-015-1731-3.
[13] Gao L, Li FS, Chen XH, et al.Radiation induces phosphorylation of STAT3 in a dose-and time-dependent manner[J].Asian Pac J Cancer Prev, 2014, 15(15):6161-6164.
[14] Fang ZH, Li YJ, Chen Z, et al.Inhibition of signal transducer and activator of transcription 3 and cyclooxygenase-2 is involved in radiosensitization of cepharanthine in HeLa cells[J].Int J Gynecol Cancer, 2013, 23(4):608-614.DOI:10.1097/IGC.0b013e31828a05fd.
[15] Pan YB, Zhou FL, Zhang RH, et al.Stat3 inhibitor stattic exhibits potent antitumor activity and induces chemo-and Radio-Sensitivity in nasopharyngeal carcinoma[J/OL].PLoS One, 2013, 8(1):e54565.[2016-01-03]http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558509/pdf/pone.0054565.pdf.DOI:10.1371/journal.pone.0054565.
[16] Adachi M, Cui C, Dodge CT, et al.Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma[J].Oral Oncol, 2012, 48(12):1220-1226.DOI:10.1016/j.oraloncology.2012.06.006.
[17] Huang CY, Tai WT, Hsieh CY, et al.A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3[J].Cancer Lett, 2014, 349(2):136-143.DOI:10.1016/j.canlet.2014.04.006.
[18] You S, Li R, Park D, et al.Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer[J].Mol Cancer Ther, 2014, 13(3):606-616.DOI:10.1158/1535-7163.MCT-13-0608.
[19] Yun UJ, Park SE, Jo YS, et al.DNA damage induces the IL-6/STAT3 signaling pathway, which has anti-senescence and growth-promoting functions in human tumors[J].Cancer Lett, 2012, 323(2):155-160.DOI:10.1016/j.canlet.2012.04.003.
[20] Liao XH, Zheng L, He HP, et al.STAT3 regulated ATR via microRNA-383 to control DNA damage to affect apoptosis in A431 cells[J].Cell Signal, 2015, 27(11):2285-2295.DOI:10.1016/j.cellsig.2015.08.005.
[21] Barry SP, Townsend PA, Knight RA, et al.STAT3 modulates the DNA damage response pathway[J].Int J Exp Pathol, 2010, 91(6):506-514.DOI:10.1111/j.1365-2613.2010.00734.x.
[22] Hu X, Yu J, Zhou X, et al.A small GTPase-like protein fragment of Mycoplasma promotes tumor cell migration and proliferation in vitro via interaction with Rac1 and Stat3[J].Mol Med Rep, 2014, 9(1):173-179.DOI:10.3892/mmr.2013.1766.
[23] Xiao H, Bid HK, Jou D, et al.A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells[J].J Biol Chem, 2015, 290(6):3418-3429.DOI:10.1074/jbc.M114.616748.
[24] You LK, Wang ZG, Li HS, et al.The role of STAT3 in autophagy[J].Autophagy, 2015, 11(5):729-739.DOI:10.1080/15548627.2015.1017192.
[25] Maycotte P, Gearheart CM, Barnard R, et al.STAT3-mediated autophagy dependence identifies subtypes of breast cancer where autophagy inhibition can be efficacious[J].Cancer Res, 2014, 74(9):2579-2590.DOI:10.1158/0008-5472.CAN-13-3470.
[26] Gong JJ, Munoz AR, Chan D, et al.STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth[J].Oncotarget, 2014, 5(9):2529-2541.
[27] Huang YH, Yang PM, Chuah QY, et al.Autophagy promotes radiation-induced senescence but inhibits bystander effects in human breast cancer cells[J].Autophagy, 2014, 10(7):1212-1228.DOI:10.4161/auto.28772.
[28] Shojaei F.Anti-angiogenesis therapy in cancer:Current challenges and future perspectives[J].Cancer Lett, 2012, 320(2):130-137.DOI:10.1016/j.canlet.2012.03.008.
[29] Zhang X, Tang J, Zhi X, et al.miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer[J].Oncotarget, 2015, 6(3):1605-1617.DOI:10.18632/oncotarget.2748.
[30] Qi J, Xia G, Huang CR, et al.JSI-124(cucurbitacin I) inhibits tumor angiogenesis of human breast cancer through reduction of STAT3 phosphorylation[J].AmJ Chin Med, 2015, 43(2):337-347.DOI:10.1142/S0192415X15500226.
[31] Kang FB, Wang L, Jia HC, et al.B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway[J].Cancer Cell Int, 2015, 15:45.DOI:10.1186/s12935-015-0195-z
[32] Li F, Gao L, Jiang Q, et al.Radiation enhances the invasion abilities of pulmonary adenocarcinoma cells via STAT3[J].Mol Med Rep, 2013, 7(6):1883-1888.DOI:10.3892/mmr.2013.1441.
[33] Cho JH, Hong WG, Jung YJ, et al.Γ-Ionizing radiation-induced activation of the EGFR-p38/ERK-STAT3/CREB-1-EMT pathway promotes the migration/invasion of non-small cell lung cancer cells and is inhibited by podophyllotoxin acetate[J/OL].Tumour Biol, 2015:1-11[2016-01-03].http://link.springer.com/article/10.1007%2Fs13277-015-4548-y.[published online ahead of print December 15, 2015].DOI:10.1007/s13277-015-4548-y.
[34] Kortylewski M, Kujawski M, Wang T, et al.Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity[J].Nat Med, 2005, 11(12):1314-1321.DOI:10.1038/nm1325.
[35] Kinjyo I, Inoue H, Hamano S, et al.Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1[J].J Exp Med, 2006, 203(4):1021-1031.DOI:10.1084/jem.20052333.
[36] Yu H, Kortylewski M, Pardoll D.Crosstalk between cancer and immune cells:role of STAT3 in the tumour microenvironment[J].Nat Rev Immunol, 2007, 7(1):41-51.DOI:10.1038/nri1995.
[37] Kim JS, Kim HA, Seong MK, et al.STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers[J].Oncotarget, 2016, 7(6):7055-7065.DOI:10.18632/oncotarget.6855.
[38] Lau J, Ilkhanizadeh S, Wang S, et al.STAT3 blockade inhibits Radiation-Induced malignant progression in glioma[J].Cancer Res, 2015, 75(20):4302-4311.DOI:10.1158/0008-5472.CAN-14-3331.
[39] Li XM, Wang HR, Lu XY, et al.Silencing STAT3 with short hairpin RNA enhances radiosensitivity of human laryngeal squamous cell carcinoma xenografts in vivo[J].Exp Ther Med, 2010, 1(6):947-953.DOI:10.3892/etm.2010.156.
[40] Bonner JA, Trummell HQ, Willey CD, et al.Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma[J].Radiother Oncol, 2009, 92(3):339-344.DOI:10.1016/j.radonc.2009.06.022.
[41] Luo Z, Wang C, Yi H, et al.Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo[J].Biomaterials, 2015, 38:50-60.DOI:10.1016/j.biomaterials.2014.10.050.
[42] Mali SB.Review of STAT3(signal transducers and activators of transcription) in head and neck cancer[J].Oral Oncol, 2015, 51(6):565-569.DOI:10.1016/j.oraloncology.2015.03.004.
[43] Siveen KS, Sikka S, Surana R, et al.Targeting the STAT3 signaling pathway in cancer:role of synthetic and natural inhibitors[J].Biochim Biophys Acta, 2014, 1845(2):136-154.DOI:10.1016/j.bbcan.2013.12.005.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[5]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[6]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[7]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[8]杨卫东,汪静.肿瘤核素靶向治疗新进展[J].国际放射医学核医学杂志,2015,39(1):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
Yang Weidong,Wang Jing.Advance progress of radionuclide target tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
[9]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
[10]王浩,周则卫,周晓靓.N-(5-硝基吲唑-3-甲酰)酪氨酸钠的制备、乏氧增敏与体内分布研究[J].国际放射医学核医学杂志,2015,39(3):235.[doi:10.3760/cma.j.issn.1673-4114.2015.03.010]
Wang Hao,Zhou Zewei,Zhou Xiaoliang.Synthesis, hypoxic radiosensitization and biodistribution of N-(5-nitroindazole-3-formyl) tyrosine sodium[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):235.[doi:10.3760/cma.j.issn.1673-4114.2015.03.010]